Keyphrases
Y Chromosome
83%
Diabetic Rats
78%
Human Y Chromosome
75%
Peru
75%
South America
50%
Haplogroup
50%
Archaeological Sites
50%
White People
50%
Amerindian Haplogroup
50%
Molecular Characterization
50%
C-13
50%
Lambayeque
50%
Brazil
50%
Polymorphism
50%
Amelogenin Gene
50%
Ancient DNA
50%
Experimental Diabetic Nephropathy
50%
Podocyte Injury
50%
Spironolactone
50%
Fibrosis
50%
Rat Model
50%
Left Ventricular Hypertrophy
50%
Northern Peru
50%
Angiotensin-converting Enzyme
50%
Atorvastatin
50%
People of Color
50%
Diabetic Cardiomyopathy
50%
Angiotensin-converting Enzyme 2 (ACE2)
50%
DYS390
41%
T-lineage
41%
Haplotype Diversity
41%
Mitochondrial Haplogroups
33%
Haplogroup B
33%
Racial Groups
33%
Peruvian
25%
African Ancestry
25%
Human Population
25%
Specific Locus
25%
Recombination Region
25%
Hispanic
25%
Genetic Tools
25%
Mestizo Population
25%
Northern Populations
25%
Moche
25%
Western Population
25%
TGF-1
21%
Podocyte
21%
Y-chromosome Haplotypes
16%
Northern Coast
16%
Single Base
16%
Religious Structure
16%
Base Change
16%
Meta-analysis
16%
Polymorphic Site
16%
Ancient Populations
16%
Tetranucleotide Repeats
16%
Anthropological Studies
16%
Element Insertion
16%
Early Peopling of the Americas
16%
Modern Civilization
16%
Conventional PCR
16%
Political Structure
16%
Statistical Methods
16%
Maternal Lineage
16%
Ancient Civilizations
16%
Restriction Fragment Length Polymorphism
16%
DYS19
16%
Genetic Structure
16%
Ancestral Population
16%
Coastal Village
16%
Alu Elements
16%
Peruvian Highlands
16%
Peruvian Coast
16%
Trinucleotide Repeats
16%
DNA Samples
16%
Civilization
16%
Population Specificity
16%
Archaeological Survey
16%
Inca
16%
Overexpression
16%
MRNA Level
16%
Collagen Content
15%
Streptozotocin
15%
Diabetic
15%
Desmin Expression
14%
Immunostain
14%
Glucose Level
14%
MRNA Expression
14%
Genetic Expression
8%
3-group
8%
Cholesterol-lowering Capacity
8%
Adverse Remodeling
8%
Cholesterol Levels
8%
Cardiac Remodeling
8%
Diabetes
8%
Diabetic Heart
8%
Intraperitoneal Injection
8%
Collagen Deposition
8%
Myocardial Hypertrophy
8%
Content Assay
8%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
78%
Heart Left Ventricle Hypertrophy
50%
Atorvastatin
50%
Rat Model
50%
Angiotensin I
50%
Fibrosis
50%
Dipeptidyl Carboxypeptidase
50%
Diabetic Cardiomyopathy
50%
Spironolactone
50%
Experimental Diabetic Nephropathy
50%
Desmin
21%
Streptozotocin
17%
Holtzman Rat
17%
Heart Ventricle Hypertrophy
10%
Heart Ventricle Remodeling
10%
Intraperitoneal Injection
10%
Kidney Hypertrophy
7%
Diabetic Nephropathy
7%
Injury
7%
Buffer
7%
Immunology and Microbiology
Y Chromosome
100%
Lineages
93%
Haplotype
75%
Haplogroup
50%
Podocyte
50%
Glucose Level
25%
Mitochondrial Haplogroup
20%
Polymerase Chain Reaction
20%
Chromosome 13
16%
Holtzman Rat
12%
Reverse Transcription Polymerase Chain Reaction
12%
Gene Expression
12%
Morphology
12%
Skeleton
10%
Restriction Fragment Length Polymorphism
10%
Gene Structure
10%
Trinucleotide Repeat
8%
Alu Sequence
8%